Arizona Heart Institute
Research from the United States, Argentina and France in cardiology provides new insights
Published in Pharma Law Weekly, August 15th, 2006
Study 1: Endoluminal grafting of descending thoracic aorta pathologies with the Gore TAG thoracic endoprosthesis is feasible and safe in higher surgical risk patients.
"Despite recent improvements in surgical technique, some patients with descending thoracic aortic pathologies are unable to undergo open surgical repair due to significant comorbidities and/or unfavorable thoracic aortic anatomy. Some of these patients might be able to tolerate a less invasive approach, such as endoluminal grafting," scientists in the United States report.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2006-08-15)
More Articles from Pharma Law Weekly
- Advanced Viral Research
Advanced Viral Research granted U.S. patent for rheumatoid arthritis - Alnylam Pharmaceuticals
Alnylam granted U.S. patent covering small interfering RNAs - American Diabetes Association
American Diabetes Association urges Senate to pass stem cell bill - Ecopia
U.S. Patent and Trademark office confirms composition-of-matter claims on Ecopia's ECO-4601 - Evotec
DAC selects Evotec as strategic partner for drug discovery collaboration on HSP90 cancer target - Foamix
Foamix names David Schuz as senior vice president, intellectual property - More from this issue of Pharma Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
